Buy stocks
Invest and track all your stocks in one place.
Suven Life Sciences LtdNSE: SUVEN
NSE: SUVEN
₹101.85
+0.05
(29 Feb)
+0.0%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹101.85
Today’s high
₹102.40
Today’s low
₹99.05
52W high
₹128.79
52W low
₹45.01
1Y
83.0%
PE
-21.35
PB
6.56
EPS (TTM)
-6.63
Dividend yield
NA
5Y
10.2%
Market cap
₹2,221.1 Cr
Volume
12,695
Average volume
88,651
Insights
SUVEN price is above its 200 day moving average
SUVEN PE is in the low end of its range over the past 2 years
SUVEN PE is in the lowest 10% across all stocks. The market is valuing it as a value stock on an earnings basis.
SUVEN has negative earnings and hence the PE is not defined
In beta. Send feedback here.
Compare with other stock
Price
₹1,618.80
₹1,027.00
₹101.85
₹1,576.20
₹6,420.40
₹3,489.10
1D
+0.2%
-0.1%
+0.0%
+0.2%
-0.1%
-0.7%
1Y
+145.6%
+121.8%
+83.0%
+64.7%
+48.9%
+23.5%
PE
41.32
21.74
-21.35
42.49
20.49
66.96
PB
5.57
2.13
6.56
6.32
3.99
7.31
EPS
39.18
47.24
-4.77
37.10
313.29
52.11
Market cap
Large
Large
Large
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2022
Revenue
₹13.5 Cr
Net income
- ₹118.3 Cr
See stock holdings
Top institutional holders
Quant Money Managers Limited
1.05%
Dimensional Fund Advisors
0.37%
SSGA Funds Management Inc
0.35%
Victory Capital Management Inc.
0.30%
State Street Global Advisors Ltd
0.22%
Top mutual fund holders
SPDR® Portfolio Emerging Markets ETF
0.29%
L&T Emerging Opps - Ser II
0.20%
CREF Stock Account
0.10%
WisdomTree India Earnings Fund
0.06%
BlackRock MSCI ACWI ex-U.S. IMI Index NL
0.04%
About Suven Life Sciences
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company's only segment is providing Research and Development services. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API) Speciality chemicals, and formulated drugs under contract research and manufacturing services. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Company address
Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, , Hyderabad, TG, 500
Key executives
Name
Title
Age
Mr. Venkateswarlu Jasti
CEO/Chairman of the Board/Director
73 yrs

FAQs

How to Buy Suven Life Sciences Ltd Stock?
What is the Share Price of Suven Life Sciences Ltd?
What is the Market Cap of Suven Life Sciences Ltd?
In which sector / industry does Suven Life Sciences Ltd operate?
What was the revenue of Suven Life Sciences Ltd?
What is the PE ratio of Suven Life Sciences Ltd?
What is the 52 week high price of Suven Life Sciences Ltd?
What is the 52 week low price of Suven Life Sciences Ltd?
Can fractional shares of Suven Life Sciences Ltd be purchased?